Edge Rewrite
everything Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a234d38beed43488

Jump to content

Certoparin sodium

From Wikipedia, the free encyclopedia
(Redirected from Certoparin)
Certoparin sodium
Clinical data
Trade namesSandoparin, Embolex
AHFS/Drugs.comInternational Drug Names
ATC code
  • none
Identifiers
CAS Number
DrugBank
ChemSpider
  • none
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.110.590 Edit this at Wikidata
Mono-Embolex®

Certoparin (trade names Sandoparin, Embolex) is an antithrombotic medication. It is a low molecular weight heparin, primarily active against factor Xa. Like other low molecular weight heparins, it is used to prevent deep venous thrombosis.[1]

References

[edit]
  1. ↑ Donadini MP, Ageno W, Guasti L, Squizzato A (July 2013). "Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies". Expert Opinion on Drug Metabolism & Toxicology. 9 (7): 901–9. doi:10.1517/17425255.2013.794787. PMID 23621639. S2CID 31020741.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Certoparin_sodium&oldid=1330777824"